Literature DB >> 4310770

"Activation" of vitamin D by the liver.

G Ponchon, A L Kennan, H F DeLuca.   

Abstract

Isolation of the liver from the circulation of rats eliminates almost completely their ability to convert [1,2]-(3)H vitamin D(3) into its biologically active metabolite, 25-hydroxycholecalciferol, as well as certain other metabolites. It is concluded that the liver is the major if not the only physiologic site of hydroxylation of vitamin D(3) (cholecalciferol) into 25-hydroxycholecalciferol. The osteodystrophy and the higher requirements for vitamin D observed in hepatic insufficiencies may be due to an inability of the liver to transform vitamin D into its metabolically active form.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4310770      PMCID: PMC297455          DOI: 10.1172/JCI106168

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Vitamin D3 and absorption of calcium in the chick.

Authors:  M E COATES; E S HOLDSWORTH
Journal:  Br J Nutr       Date:  1961       Impact factor: 3.718

2.  Vitamin D and growth.

Authors:  H STEENBOCK; D C HERTING
Journal:  J Nutr       Date:  1955-12-10       Impact factor: 4.798

3.  The synthesis of [1,2-3H]vitamin D3 and the tissue localization of a 0.25-mu-g (10 IU) dose per rat.

Authors:  P F Neville; H F DeLuca
Journal:  Biochemistry       Date:  1966-07       Impact factor: 3.162

4.  Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption.

Authors:  G R Thompson; B Lewis; C C Booth
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

5.  The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo.

Authors:  M R Haussler; J F Myrtle; A W Norman
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

6.  Biologically active metabolite of vitamin D3 from bone, liver, and blood serum.

Authors:  J Lund; H F DeLuca
Journal:  J Lipid Res       Date:  1966-11       Impact factor: 5.922

7.  Subcellular location of vitamin D and its metabolites in intestinal mucosa after a 10-IU dose.

Authors:  S J Stohs; H F DeLuca
Journal:  Biochemistry       Date:  1967-11       Impact factor: 3.162

8.  The effect of bile, bile acids and detergents on calcium absorption in the chick.

Authors:  D D Webling; E S Holdsworth
Journal:  Biochem J       Date:  1965-11       Impact factor: 3.857

9.  [Bone involvement in hepatobiliary diseases in infants & children].

Authors:  D ALAGILLE
Journal:  Bull Mem Soc Med Hop Paris       Date:  1958 Oct 24-31

10.  Studies of antiricketic activity in sera from patients with disorders of calcium metabolism and preliminary observations on the mode of transport of vitamin D in human serum.

Authors:  W C THOMAS; H G MORGAN; T B CONNOR; L HADDOCK; C E BILLS; J E HOWARD
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

View more
  78 in total

1.  Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis.

Authors:  Xiang Wang; Weiping Li; Ying Zhang; Yang Yang; Guijun Qin
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 2.  Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes.

Authors:  Bruce W Hollis; Carol L Wagner
Journal:  J Clin Endocrinol Metab       Date:  2013-10-08       Impact factor: 5.958

3.  Comparative studies on the 25-hydroxylations of cholecalciferol and 1 alpha-hydroxycholecalfierol in perfused rat liver.

Authors:  M Fukushima; Y Nishil; M Suzuki; T Suda
Journal:  Biochem J       Date:  1978-03-15       Impact factor: 3.857

Review 4.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

5.  1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells.

Authors:  Matthew R Durk; Gary N Y Chan; Christopher R Campos; John C Peart; Edwin C Y Chow; Eason Lee; Ronald E Cannon; Reina Bendayan; David S Miller; K Sandy Pang
Journal:  J Neurochem       Date:  2012-11-01       Impact factor: 5.372

6.  Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.

Authors:  R G Wong; A W Norman; C R Reddy; J W Coburn
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

7.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

8.  Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.

Authors:  J E Compston; L W Horton; R P Thompson
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

9.  Hyperparathyroidism in hepatobiliary disease in infancy.

Authors:  A Kobayashi; S Kawai; T Utsunomiya; Y Ohbe
Journal:  Eur J Pediatr       Date:  1975-12-09       Impact factor: 3.183

10.  Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense.

Authors:  Sif Hansdottir; Martha M Monick; Sara L Hinde; Nina Lovan; Dwight C Look; Gary W Hunninghake
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.